The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ISLB 2021 | Liquid biopsy: Role of the advocacy for lung cancer

Name: Liquid biopsy: Role of the advocacy for lung cancer
Uploaded: 2021-10-18T00:00:00Z
Duration: 1 min 42 s
Description: Amy Moore, PhD, LUNGevity Foundation, San Carlos, CA, explains the role of patient advocacy in lung cancer, specifically in relation to liquid biopsy and genomic profiling. This interview took place at the International Society of Liquid Biopsy (ISLB) 2021 Virtual Meeting.

Amy Moore • 18 Oct 2021

ISLB 2021

Lung Cancer

Amy Moore, PhD, LUNGevity Foundation, San Carlos, CA, explains the role of patient advocacy in lung cancer, specifically in relation to liquid biopsy and genomic profiling. This interview took place at the International Society of Liquid Biopsy (ISLB) 2021 Virtual Meeting.